Enanta Pharmaceuticals Inc (ENTA)

CIK 1177648 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Enanta Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0000908834-26-000416
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003479
Aug 12, 202610-Q0001193125-26-345719
Aug 10, 202640002064832-26-000266
Aug 10, 20268-K0001193125-26-342336
Jul 2, 2026424B50001193125-26-294828
Jul 2, 20268-K0001193125-26-294837
Jun 23, 20268-K0001193125-26-279803
Jun 18, 20268-K0001193125-26-274950
May 13, 2026S-80001193125-26-220600
May 13, 202610-Q0001193125-26-220572
May 11, 20268-K0001193125-26-216735
Mar 26, 20268-K0001193125-26-125113
Mar 26, 2026SCHEDULE 13G/A0000102909-26-001192
Mar 13, 202640002064832-26-000142
Mar 13, 202640002064832-26-000141
Mar 13, 202640002064832-26-000143
Mar 13, 202640002064832-26-000138
Mar 13, 202640002064832-26-000140
Mar 13, 202640002064832-26-000139
Mar 12, 20268-K0001193125-26-104109
Feb 20, 2026EFFECT9999999995-26-000642
Feb 13, 2026SCHEDULE 13G/A0001172661-26-000711
Feb 13, 202640002064832-26-000012
Feb 13, 202640002064832-26-000016